Back to Newsroom
Back to Newsroom

NYSE: BMY Shareholder Alert: Update in Lawsuit against Bristol-Myers Squibb Co announced by Shareholders Foundation

Tuesday, 09 February 2021 08:15 AM

Shareholders Foundation, Inc.

Topic:
Lawsuits

SAN DIEGO, CA / ACCESSWIRE / February 9, 2021 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Bristol-Myers Squibb Co (NYSE:BMY) shares.

Investors, who purchased shares of Bristol-Myers Squibb Co (NYSE: BMY) in 2014 or earlier and continue to hold any of those Bristol-Myers Squibb Co (NYSE: BMY shares, have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.

On February 9, 2018, a lawsuit was filed against Bristol-Myers Squibb Co (NYSE: BMY. The plaintiff alleged that the Defendants failed to disclose that Bristol-Myers' CheckMate-026 trial was more likely to fail than Defendants were representing, that Bristol- Myers' CheckMate-026 trial failed more severely than the Company indicated it did in the Company's August 5, 2016 announcements and disclosures, and that, as a result of the foregoing, Defendants' statements about Bristol-Myers' business, operations, and prospects, were materially false and/or misleading and/or lacked a reasonable basis.

On May 16, 2018, the Court issued an Order appointing Lead Plaintiffs and Counsel. On July 16, 2018, a consolidated amended Complaint was filed and on September 10, 2018, the defendants filed a Motion to Dismiss the consolidated amended Complaint.

On September 30, 2019, the Court issued an Order granting Defendants' Motion to Dismiss but gave leave to amend the Complaint.

On October 29, 2019, a consolidated second amended Complaint was filed and on December 13, 2019, the defendants filed their Motion to Dismiss the consolidated second amended Complaint.

On September 30, 2020, the Court issued an Order granting Defendants' Motion to Dismiss. The case was dismissed with prejudice.

On October 29, 2020, a notice appealing the Court's Dismissal Order was filed.

Those who purchased Bristol-Myers Squibb Co (NYSE: BMY) shares should contact the Shareholders Foundation, Inc.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
[email protected]
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

SOURCE: Shareholders Foundation, Inc.

Topic:
Lawsuits
Back to newsroom
Back to Newsroom
Share by: